ADMA ADMA BIOLOGICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 6 analyst firms say about ADMA BIOLOGICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
5 rated views · 6 analyst/firm records · 6 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8022
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8027
Recent analyst activity · last 90 days
Our tracked history has 3 reports on ADMA from 3 analyst firms in the last 90 days (6 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Cantor Fitzgerald raised its target from $12.00 (set 25 Mar 2026) to $13.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Canaccord Genuity | Gary Nachman | Buy | 6 Aug 2026 | 18.00 USD |
| Cantor Fitzgerald | Kristen Kluska | Hold | 26 Mar 2026 | 12.00 USD · 25 Mar 2026 |
| Mizuho | Anthony Petrone | Buy | 15 Jul 2026 | 17.00 USD |
| Raymond James | Ryan Deschner | Buy | 10 Jun 2026 | 21.00 USD |
| Weiss Ratings | Unnamed analyst | — | 14 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 2 Sep 2026 | 11.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:50 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.